The GCC and UAE diabetes devices market size is anticipated to reach USD 4.72 billion by 2030 and is set to grow at 7.1% CAGR from 2023 to 2030. Factors such as the increasing prevalence of diabetes, rapid technological advancements, and increasing awareness related to diabetes preventive care are all augmenting the market growth during the forecast period. For instance, in December 2021, Sanofi signed a contract with the Dasman Diabetes Institute and Research Center (DDI), a research institute & diabetes treatment center in Kuwait, to enhance diabetes control and prevention in the country.
Diabetes is a rapidly growing disease. Some of the highest diabetes prevalence rates in the world are found in the countries of the Gulf Cooperation Council. The increase in unhealthy living continues to lead to a more unhealthy population in the region. According to International Diabetes Federation, in 2021, there were about 0.8 million patients suffering from diabetes in Kuwait, and this number is expected to increase to 1.0 million by 2045.
Over the past few decades, diabetes-related research activity has been observed to be low in this region. However, an increase in research funding and collaborations between local & international researchers and institutes are expected to boost segment growth. For instance, in January 2022, the Saudi Health Council signed a memorandum of understanding with Sanofi, a French healthcare corporation, to collaborate on diabetes research and development.
The key market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, collaborations, and expansions. For instance, in August 2022, Abbott partnered with WW International, Inc. (WeightWatchers). Through this partnership, both companies will combine the weight management program of WeightWatchers for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience. It will offer knowledge & insights on how to improve their diet, lower the blood sugar levels of patients, and ultimately, help consumers take back control of their health.
This product will be delivered within 1-3 business days.
Diabetes is a rapidly growing disease. Some of the highest diabetes prevalence rates in the world are found in the countries of the Gulf Cooperation Council. The increase in unhealthy living continues to lead to a more unhealthy population in the region. According to International Diabetes Federation, in 2021, there were about 0.8 million patients suffering from diabetes in Kuwait, and this number is expected to increase to 1.0 million by 2045.
Over the past few decades, diabetes-related research activity has been observed to be low in this region. However, an increase in research funding and collaborations between local & international researchers and institutes are expected to boost segment growth. For instance, in January 2022, the Saudi Health Council signed a memorandum of understanding with Sanofi, a French healthcare corporation, to collaborate on diabetes research and development.
The key market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, collaborations, and expansions. For instance, in August 2022, Abbott partnered with WW International, Inc. (WeightWatchers). Through this partnership, both companies will combine the weight management program of WeightWatchers for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience. It will offer knowledge & insights on how to improve their diet, lower the blood sugar levels of patients, and ultimately, help consumers take back control of their health.
GCC And UAE Diabetes Devices Market Report Highlights
- Based on services, the pharma, drugs & supplies segment accounted for the largest market share in 2022, owing to the growing demand for efficient medication therapies for diabetes treatment
- Based on distribution channel, the hospital pharmacies segment dominated the market in 2022 and is expected to continue dominating over the forecast period
- The online pharmacies segment is expected to grow at the fastest rate over the forecast period owing to the increasing patient awareness about online pharmacies
- Based on end-use, the hospital segment held the largest market share in 2022, owing to the adoption of advanced diabetes devices by hospitals
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the GCC And UAE Diabetes Devices Market
What is the estimated value of the GCC And UAE Diabetes Devices Market?
What is the growth rate of the GCC And UAE Diabetes Devices Market?
What is the forecasted size of the GCC And UAE Diabetes Devices Market?
Who are the key companies in the GCC And UAE Diabetes Devices Market?
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | December 2022 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD
| USD 2.92 Billion |
Forecasted Market Value ( USD
| USD 4.72 Billion |
Compound Annual Growth Rate | 7.1% |
Regions Covered | Middle East, United Arab Emirates |
No. of Companies Mentioned | 11 |
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. GCC and UAE Diabetes Devices Market Variables, Trends & Scope
Chapter 4. GCC and UAE Diabetes Devices Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)
Chapter 5. GCC and UAE Diabetes Devices Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
Chapter 6. GCC and UAE Diabetes Devices Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
Chapter 7. GCC and UAE Diabetes Devices Market: Regional Market Analysis, 2018 - 2030 (USD Million)
Chapter 8. GCC and UAE Diabetes Devices Market - Competitive Analysis
List of Tables
List of Figures
Companies Mentioned
- Medtronic
- Abbot Laboratories
- Ascensia Diabetes Care Holdings
- Dexcom
- F. Hoffmann- La Roche AG
- Sanofi
- Novo Nordisk A/S
- Insulet Corporation
- Ypsomed AG
- Eli Lily
- Astra Zeneca
Methodology
LOADING...